<DOC>
	<DOCNO>NCT02091024</DOCNO>
	<brief_summary>The investigator perform 12-week , randomize , double-blind , placebo-controlled human trial evaluate efficacy safety Ecklonia cava extract hyperlipidemia .</brief_summary>
	<brief_title>Blood Lipid-lowering Effect Brown Alga Ecklonia Cava</brief_title>
	<detailed_description>The investigator perform 12-week , randomize , double-blind , placebo-controlled human trial evaluate efficacy safety Ecklonia cava extract hyperlipidemia . The investigator measure improvement lipid profile , include total cholesterol , triglyceride , HDL-cholesterol , LDL-cholesterol .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Mild hypercholesterolemic subject ( ≥200mg/dL total cholesterol ≥110mg/dL LDLcholesterol ) Selfreported pregnancy , lactation Prevalent heart disease , cancer , renal disorder , diabetes mellitus , use lipidlowering drug</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>